Impact of Chronic Liver Disease in Intensive Care Unit Acquired Pneumonia: a Prospective Study
Overview
Authors
Affiliations
Purpose: To assess the impact of chronic liver disease (CLD) on ICU-acquired pneumonia.
Methods: This was a prospective, observational study of the characteristics, microbiology, and outcomes of 343 consecutive patients with ICU-acquired pneumonia clustered according to the presence of CLD.
Results: Sixty-seven (20%) patients had CLD (67% had liver cirrhosis, LC), MELD score 26 ± 9, 20% Child-Pugh class C). They presented higher severity scores than patients without CLD both on admission to the ICU (APACHE II, LC 19 ± 6 vs. other CLD 18 ± 6 vs. no CLD 16 ± 6; p < 0.001; SOFA, 10 ± 3 vs. 8 ± 4 vs. 7 ± 3; p < 0.001) and at onset of pneumonia (APACHE II, 19 ± 6 vs. 17 ± 6 vs. 16 ± 5; p = 0.001; SOFA, 11 ± 4 vs. 9 ± 4 vs. 7 ± 3; p < 0.001). Levels of CRP were lower in patients with LC than in the other two groups (day 1, 6.5 [2.5-11.5] vs. 13 [6-23] vs. 15.5 [8-24], p < 0.001, day 3, 6 [3-12] vs. 16 [9-21] vs. 11 [5-20], p = 0.001); all the other biomarkers were higher in LC and other CLD patients. LC patients had higher 28- and 90-day mortality (63 vs. 28%, p < 0.001; 72 vs. 38%, p < 0.001, respectively) than non-CLD patients. Presence of LC was independently associated with decreased 28- and 90-day survival (95% confidence interval [CI], 1.982-17.250; p = 0.001; 95% confidence interval [CI], 2.915-20.699, p = 0.001, respectively).
Conclusions: In critically ill patients with ICU-acquired pneumonia, CLD is associated with a more severe clinical presentation and poor clinical outcomes. Moreover, LC is independently associated with 28- and 90-day mortality. The results of this study are important for future trials focused on mortality.
Reyes L, Torres A, Olivella-Gomez J, Ibanez-Prada E, Nseir S, Ranzani O Antibiotics (Basel). 2025; 14(2).
PMID: 40001371 PMC: 11851455. DOI: 10.3390/antibiotics14020127.
Amodio E, Schreiber P, Faes Hesse M, Wolfensberger A Infect Dis Rep. 2024; 16(2):228-238.
PMID: 38525765 PMC: 10961785. DOI: 10.3390/idr16020018.
Levy C, Gaudet A, Jaillette E, Reignier J, Lassailly G, Balduyck M J Clin Med. 2022; 11(20).
PMID: 36294314 PMC: 9604551. DOI: 10.3390/jcm11205994.
Demirtas C, Keklikkiran C, Ergenc I, Erturk Sengel B, Eskidemir G, Cinel I Int J Clin Pract. 2021; 75(9):e14363.
PMID: 33993597 PMC: 8237050. DOI: 10.1111/ijcp.14363.
Lippi G, de Oliveira M, Henry B Eur J Gastroenterol Hepatol. 2020; 33(1):114-115.
PMID: 32282549 PMC: 7690326. DOI: 10.1097/MEG.0000000000001742.